Scientific advice

A fee-based advisory service for developers of a range of health technologies.

Our confidential advice helps the life sciences industry develop high quality evidence generation plans that capture what matters to patients and the healthcare system.

Make an enquiry

NICE methods technical workshop

Decision modifiers, real-world evidence, and exploring uncertainty. Tuesday 21 June 2022, 1pm to 5pm.

Find out more and register here.

What we do

Our advisory services:

  • help you develop evidence that shows the value of your product
  • provide detailed feedback on your evidence generation plans
  • help build cost-effectiveness measures into your evidence generation plans
  • receive input from leading experts within the NHS and academia
  • incorporate the perspective of patient experts
  • help companies understand health technology assessment and the perspective of decision-makers.
Case studies and testimonials

Our services

We have a range of services focused on:

We are also collaborating with system partners to develop a multi-agency advisory service for artificial intelligence (AI) and data-driven technologies (MAAS).

When to use our services

We have a range of services that provide advice at various stages of the development process.

When seeking advice on specific clinical trials or studies, we recommend engaging with us before finalising your protocols. You can seek advice in areas such as health economics after your trials are underway.

The timelines below show where our services can fit into the development process for medtech or pharmaceutical products.

COVID-19

We can provide streamlined advice for researchers developing novel diagnostics or therapeutics for COVID-19. Please get in touch through our enquiries form below.

Make an enquiry

Working in collaboration with the NIHR, we have produced a guide on clinical evidence generation for developers of medicinal products for COVID-19.

Medtech

  • Proof of concept, prototype phase

    Get an early insight into building an evidence base to demonstrate the value of your technology and meet the needs of HTA bodies, commissioners and payers with our META Tool©.

  • Evidence generation phase

    Identify any gaps in your evidence generation plans and receive information on the next steps using our META Tool©.

    Optimise your clinical trial/study plans by getting answers to your questions and receiving key insights through our advisory services.

  • Adoption phase

    Identify any gaps in the existing evidence base for your technology and receive information on the next steps with the META Tool©.

Pharmaceuticals

  • Pre-clinical / Phase 1

    Initiate early dialogue with us when your technology does not fit the conventional development paradigm and there is uncertainty around your evidence generation plans.

  • Phase 2 and 3

    Optimise your clinical trial/study plans by getting answers to your questions and receiving key insights through our advisory services.

  • Post phase 3, pre-authorisation

    Optimise your economic strategy and/or any additional clinical trial/study plans by getting answers to your questions and receiving key insights through our advisory services.

    Seek expert technical advice on the structure, transparency and overall suitability of your economic model with our PRIMA service.

  • Post-authorisation

    Optimise any further clinical trial/study plans by getting answers to your questions and receiving key insights through our advisory services.

    Seek expert technical advice on the structure, transparency and overall suitability of your economic model with our PRIMA service.


More information

Meet the team

Find out about the scientific advice team, which includes the technical team and coordination team.

Frequently asked questions

Find out more about what you can seek advice on and what's involved in the process.

News and resources

Read the latest news and information from the scientific advice team.

Follow us on Twitter @NICESciAdvice